Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Print
Session IX: Hepatocellular Cancer
SO-12: Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients with advanced hepatocellular carcinoma (aHCC): 5-year results from CheckMate 040
Thursday, June 30, 2022
15:42 – 15:50
Location: Auditorium A; Level 0
Abstract Presenter(s)
IM
Ignacio Melero
